German federal Health Minister Horst Seehofer says economies areimperative after the health funds posted a 1996 deficit of 6.3 billion Deutschemarks ($3.70 billion), 3.9 billion marks for western Germany and 2.4 billion marks for the eastern states. The deficit is however lower than expected.
The main legislative revisions planned to support this policy can be forced through by the coalition government without the agreement of the parliamentary upper house, and will increase pressure on the funds to reach stricter agreements on economies with the medical profession and other health care providers.
Also, the tendency for insured people to switch to funds offering better value for money is more extensive than expected. 1996 spending in several health service sectors rose above 5%, with drug spending up 6.3%. Average spending on the full range of treatments rose 3% against a rise in contribution income of only 1.4%.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze